We are live on
!
Find out more
SCM
Suffolk Capital Management Portfolio holdings
AUM
$521M
1-Year Est. Return
9.79%
This Fund
S&P 500
This Quarter
Est. Return
+2.85%
1 Year Est. Return
-9.79%
3 Year Est. Return
+48.57%
5 Year Est. Return
+94.78%
10 Year Est. Return
–
AUM
$841M
AUM Growth
-$11.9M
(-1.4%)
Cap. Flow
-$27.5M
Cap. Flow
% of AUM
-3.27%
Top 10 Holdings %
Top 10 Hldgs %
20.85%
Holding
159
New
21
Increased
47
Reduced
62
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$13.8M |
| 2 |
Mastercard
MA
|
+$13.6M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$13.4M |
| 4 |
Xylem
XYL
|
+$13M |
| 5 |
DuPont de Nemours
DD
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$13.9M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$13.6M |
| 3 |
Adobe
ADBE
|
+$13.6M |
| 4 |
Humana
HUM
|
+$12.5M |
| 5 |
General Motors
GM
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.9% |
| 2 | Technology | 17.04% |
| 3 | Financials | 13.84% |
| 4 | Industrials | 13.66% |
| 5 | Communication Services | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Biogen
BIIB
$30B
| $1.27M | 0.15% |
3,140
-17,525
| -85% | -$7.03M |
|
|
VIVS
127
VivoSim Labs
VIVS
$1.2M
| $914K | 0.11% |
+1,010
| New | +$1.13M |
|
128
Immersion
IMMR
$251M
| $895K | 0.11% |
+70,650
| New | +$798K |
|
129
Pfizer
PFE
$143B
| $853K | 0.1% |
26,815
+1,956
| +8% | +$63.7K |
|
130
US Bancorp
USB
$98.2B
| $226K | 0.03% |
5,215
+315
| +6% | +$13.8K |
|
131
Blackrock
BLK
$169B
| $211K | 0.03% |
610
| – | – |
|
132
Acadia Healthcare
ACHC
$2.76B
| – | – |
-43,439
| Closed | -$3.11M |
|
|
133
Adobe
ADBE
$99.5B
| – | – |
-183,649
| Closed | -$13.6M |
|
|
AXON
134
Axon Enterprise
AXON
$42.5B
| – | – |
-115,741
| Closed | -$2.79M |
|
135
EOG Resources
EOG
$79.2B
| – | – |
-34,824
| Closed | -$3.19M |
|
136
The Greenbrier Companies
GBX
$1.52B
| – | – |
-6,516
| Closed | -$378K |
|
|
137
General Motors
GM
$80.4B
| – | – |
-316,059
| Closed | -$11.9M |
|
138
Guidewire Software
GWRE
$12.6B
| – | – |
-45,809
| Closed | -$2.41M |
|
|
139
Humana
HUM
$43.7B
| – | – |
-70,231
| Closed | -$12.5M |
|
140
IBM
IBM
$211B
| – | – |
-34,936
| Closed | -$5.36M |
|
141
International Paper
IP
$21.6B
| – | – |
-4,368
| Closed | -$230K |
|
142
Invesco
IVZ
$13.1B
| – | – |
-5,300
| Closed | -$210K |
|
143
El Pollo Loco
LOCO
$501M
| – | – |
-85,400
| Closed | -$2.19M |
|
144
M&T Bank
MTB
$35.7B
| – | – |
-12,177
| Closed | -$1.55M |
|
145
Puma Biotechnology
PBYI
$404M
| – | – |
-8,762
| Closed | -$2.07M |
|
146
Qorvo
QRVO
$7.99B
| – | – |
-16,742
| Closed | -$1.33M |
|
147
Molson Coors Class B
TAP
$7.79B
| – | – |
-103,336
| Closed | -$7.69M |
|
|
THS
148
DELISTED
Treehouse Foods
THS
| – | – |
-31,211
| Closed | -$2.65M |
|
|
TRUE
149
DELISTED
TrueCar
TRUE
| – | – |
-122,527
| Closed | -$2.19M |
|
150
UnitedHealth
UNH
$376B
| – | – |
-95,629
| Closed | -$11.3M |
|
Similar funds
CFIC
MCTIC
BTNA
RCM
OTC
SFM
APFBOT
NCMW
Suffolk Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Suffolk Capital Management held 159 positions worth $841M, down 1.4% from $853M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Suffolk Capital Management withdrew a net $27.5M in Q2 2015, closing 27 positions and reducing 62 holdings. Its most notable exit was Clovis Oncology, Inc., an estimated $13.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
Against the trend, Suffolk Capital Management opened a new position in Lowe's Companies worth $13M.
- Suffolk Capital Management's largest Q2 2015 buy was Lowe's Companies: 193,964 shares worth $13M.
- Suffolk Capital Management added most to RECEPTOS INC COM STK (DE) in Q2 2015, an estimated $7.8M increase.
- Suffolk Capital Management's biggest Q2 2015 reduction was RTX Corp, cutting an estimated $10.1M.
- Suffolk Capital Management fully exited Clovis Oncology, Inc. in Q2 2015, selling an estimated $13.9M.
- Suffolk Capital Management's ten largest holdings make up 21% of its $841M portfolio in Q2 2015.
- Suffolk Capital Management opened 21 new positions and closed 27 in Q2 2015.
- Suffolk Capital Management's portfolio value fell 1.4% quarter-over-quarter to $841M.
Based on Suffolk Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.